Clinical Trials in Dallas

Showing 741-760 of 8,354 trials

A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma

NCT03519997

This is a non-randomized, open-label, multi-site phase II therapeutic trial of pembrolizumab and bavituximab in patients with locally advanced HCC. Locally advanced or metastatic HCC is defined as disease that is not amenable to surgical and/or locoregional therapies. Subjects must not have received prior systemic therapy for advanced HCC in keeping with the first-line setting of this study.

Hepatocellular Carcinoma

David Hsieh35 participantsStarted Apr 2018

Dallas, Texas, United States • Dallas, Texas, United States

RECRUITINGPHASE1/PHASE2< 1 mile

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

This study is to evaluate the safety, tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with KRAS G12C-mutated solid tumors.

Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma

Revolution Medicines, Inc.534 participantsStarted Nov 2023

Duarte, California, United States • Orange, California, United States • Sacramento, California, United States +50 more locations

A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Find Trials by Condition in Dallas

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

A Study of Navenibart in Participants With Hereditary Angioedema

A Study of AZD0120 in Autoimmune Diseases

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

Intratumoral PH-762 for Cutaneous Carcinoma